Catherine Wood's DRTS Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 292,134 shares of Alpha Tau Medical Ltd. (DRTS) worth $2.07 M, representing 0.02% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in DRTS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Alpha Tau Medical (DRTS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Alpha Tau Medical (DRTS) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +292,134 | New Buy | 292,134 | $7.07 |
Catherine Wood's Alpha Tau Medical Investment FAQs
Catherine Wood first purchased Alpha Tau Medical Ltd. (DRTS) in Q1 2026, acquiring 292,134 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Alpha Tau Medical Ltd. (DRTS) for 1 quarters since Q1 2026.
Catherine Wood's largest addition to Alpha Tau Medical Ltd. (DRTS) was in Q1 2026, adding 292,134 shares worth $2.07 M.
According to the latest 13F filing for Q1 2026, Catherine Wood's firm, Ark Investment Management LLC, owns 292,134 shares of Alpha Tau Medical Ltd. (DRTS), valued at approximately $2.07 M.
As of the Q1 2026 filing, Alpha Tau Medical Ltd. (DRTS) represents approximately 0.02% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Alpha Tau Medical Ltd. (DRTS) was 292,134 shares, as reported at the end of Q1 2026.